Exelixis Inc Operating Leases, Rent Expense, Sublease Rentals
Exelixis Inc (EXEL) reported Operating Leases, Rent Expense, Sublease Rentals of $1.23 million for the 12-month period ending 2017-12-29, per its 10-K filed 2020-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeasesRentExpenseSubleaseRentals1 · last filed 2020-02-25
- Exelixis Inc operating leases, rent expense, sublease rentals for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- Exelixis Inc operating leases, rent expense, sublease rentals for the quarter ending 2017-06-30 was $306.00K, a 65.81% decline year-over-year.
- Exelixis Inc operating leases, rent expense, sublease rentals for the quarter ending 2016-12-31 was $963.00K.
- Exelixis Inc operating leases, rent expense, sublease rentals for the quarter ending 2016-09-30 was $908.00K.
- Exelixis Inc operating leases, rent expense, sublease rentals for fiscal 2017 was $1.23M, a 65.97% decline from fiscal 2016.
- Exelixis Inc operating leases, rent expense, sublease rentals for fiscal 2016 was $3.60M.
- Exelixis Inc operating leases, rent expense, sublease rentals for fiscal 2016 was $3.55M, a 31.74% decline from fiscal 2016.
- Exelixis Inc operating leases, rent expense, sublease rentals for fiscal 2016 was $5.21M.
| Period end | Operating Leases, Rent Expense, Sublease Rentals 3 month | Operating Leases, Rent Expense, Sublease Rentals 6 month | Operating Leases, Rent Expense, Sublease Rentals 9 month | Operating Leases, Rent Expense, Sublease Rentals 12 month |
|---|---|---|---|---|
| 2017-12-29 | $1.23M 10-K · filed 2020-02-25 | |||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-01 | $306.00K derived: sum of 2 quarters · filed 2017-11-01 | $1.23M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $306.00K 10-Q · filed 2017-08-02 | $1.23M 10-Q · filed 2017-08-02 | ||
| 2016-12-31 | $963.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $1.87M derived: sum of 2 quarters · filed 2017-11-01 | $2.77M derived: sum of 3 quarters · filed 2017-11-01 | $3.60M 10-K · filed 2017-02-27 |
| 2016-12-30 | $3.55M 10-K · filed 2018-02-26 | |||
| 2016-09-30 | $908.00K 10-Q · filed 2017-11-01 | $1.80M derived: sum of 2 quarters · filed 2017-11-01 | $2.64M 10-Q · filed 2017-11-01 | |
| 2016-06-30 | $895.00K 10-Q · filed 2017-08-02 | $1.73M 10-Q · filed 2017-08-02 | ||
| 2016-01-01 | $5.21M 10-K · filed 2018-02-26 | |||
| 2015-12-31 | $5.20M 10-K · filed 2017-02-27 | |||
| 2014-12-31 | $4.90M 10-K · filed 2017-02-27 | |||
| 2013-12-31 | $4.10M 10-K · filed 2016-02-29 | |||
| 2012-12-31 | $3.80M 10-K · filed 2015-03-02 | |||
| 2011-12-31 | $1.90M 10-K · filed 2014-02-20 | |||
| 2010-12-31 | $300.00K 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |